Specify a stock or a cryptocurrency in the search bar to get a summary
CVRx Inc
CVRXCVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Address: 9201 West Broadway Avenue, Minneapolis, MN, United States, 55445
Analytics
WallStreet Target Price
16.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CVRX
Dividend Analytics CVRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CVRX
Stock Valuation CVRX
Financials CVRX
Results | 2019 | Dynamics |